LEVOTRIM

This brand name is authorized in Nigeria.

Active ingredients

The drug LEVOTRIM contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3736	Film coated tablet	Levotrim TAB_FILM_COATED 500 mg	163 Levofloxacin Hemihydrate B4-3736 Levotrim Levofloxacin, Microcrystalline Cellulose Mcc Ph, Croscarmellose Sodium, Povidone (Pvp K-), Colloidal Silicon Dioxide, Purified Water, Magnesium Stearate Respiratory Drugs Oral 500 mg, Tablet, Film Coated Prescription Only Medicine (Pom) Nemel Pharmaceutical Industry Nemel Pharmaceuticals Limited Nigeria 2021-03-29 2026-03-28	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3736